Journal of Biosciences

, Volume 32, Issue 3, pp 531–536

Three-dimensional structure of heat shock protein 90 from Plasmodium falciparum: molecular modelling approach to rational drug design against malaria

  • Ranjit Kumar
  • Soundara Raghavan Pavithra
  • Utpal Tatu
Article

Abstract

We have recently implicated heat shock protein 90 from Plasmodium falciparum (PfHsp90) as a potential drug target against malaria. Using inhibitors specific to the nucleotide binding domain of Hsp90, we have shown potent growth inhibitory effects on development of malarial parasite in human erythrocytes. To gain better understanding of the vital role played by PfHsp90 in parasite growth, we have modeled its three dimensional structure using recently described full length structure of yeast Hsp90. Sequence similarity found between PfHsp90 and yeast Hsp90 allowed us to model the core structure with high confidence. The superimposition of the predicted structure with that of the template yeast Hsp90 structure reveals an RMSD of 3.31 Å. The N-terminal and middle domains showed the least RMSD (1.76 Å) while the more divergent C-terminus showed a greater RMSD (2.84 Å) with respect to the template. The structure shows overall conservation of domains involved in nucleotide binding, ATPase activity, co-chaperone binding as well as inter-subunit interactions. Important co-chaperones known to mdulate Hsp90 function in other eukaryotes are conserved in malarial parasite as well. An acidic stretch of amino acids found in the linker region, which is uniquely extended in PfHsp90 could not be modeled in this structure suggesting a flexible conformation. Our results provide a basis to compare the overall structure and functional pathways dependent on PfHsp90 in malarial parasite. Further analysis of differences found between human and parasite Hsp90 may make it possible to design inhibitors targeted specifically against malaria.

Keywords

Heat shock Hsp90 malaria molecular modeling structure 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ali M M, Roe S M, Vaughan C K, Meyer P, Panaretou B, Piper P W, Prodromou C and Pearl L H 2006 Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex; Nature (London) 440 1013–1017CrossRefGoogle Scholar
  2. Banumathy G, Singh V, Pavithra S R and Tatu U 2003 Heat shock protein 90 function is essential for Plasmodium falciparum growth in human erythrocytes; J. Biol. Chem. 278 18336–18345PubMedCrossRefGoogle Scholar
  3. Borkovich K A, Farrelly F W, Finkelstein D B, Taulien J and Lindquist S 1989 Hsp82 is an essential protein that is required in higher concentrations for growth of cells at higher temperatures; Mol. Cell. Biol. 9 3919–3930PubMedGoogle Scholar
  4. Cowen L E and Lindquist S 2005 Hsp90 potentiates the rapid evolution of new traits drug resistance in diverse fungi; Science 309 2185–2189PubMedCrossRefGoogle Scholar
  5. Cutforth T and Rubin G M 1994 Mutations in Hsp83 and cdc37 impair signaling by the sevenless receptor tyrosine kinase in Drosophila; Cell 77 1027–1036PubMedCrossRefGoogle Scholar
  6. Harris S F, Shiau A K and Agard D A 2004 The crystal structure of the carboxy-terminal dimerization domain of htpG, the Escherichia coli Hsp90, reveals a potential substrate binding site; Structure 12 1087–1097PubMedCrossRefGoogle Scholar
  7. Kumar R, Adams B, Musiyenko A, Shulyayeva O and Barik S 2005b The FK506-binding protein of the malaria parasite, Plasmodium falciparum, is a FK506-sensitive chaperone with FK506-independent calcineurin-inhibitory activity; Mol. Biochem. Parasitol. 141 163–173PubMedCrossRefGoogle Scholar
  8. Kumar R, Musiyenko A and Barik S 2005a Plasmodium falciparum calcineurin and its association with heat shock protein 90 mechanisms for the antimalarial activity of cyclosporin A and synergism with geldanamycin; Mol. Biochem. Parasitol. 141 29–37PubMedCrossRefGoogle Scholar
  9. Kumar R, Musiyenko A and Barik S 2003 The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin; Malar. J. 2 30PubMedCrossRefGoogle Scholar
  10. Maloney A and Workman P 2002 HSP90 as a new therapeutic target for cancer therapy the story unfolds; Expert. Opin. Biol. Ther. 2 3–24PubMedCrossRefGoogle Scholar
  11. Pavithra S R, Banumathy G, Joy O, Singh V and Tatu U 2004 Recurrent fever promotes Plasmodium falciparum development in human erythrocytes; J. Biol. Chem. 279 46692–46699PubMedCrossRefGoogle Scholar
  12. Pearl L H and Prodromou C 2006 Structure and mechanism of the hsp90 molecular chaperone machinery; Annu. Rev. Biochem. 75 271–294PubMedCrossRefGoogle Scholar
  13. Pratt W B and Toft D O 2003 Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery; Exp. Biol. Med (Maywood). 228 111–133Google Scholar
  14. Queitsch C, Sangster T A and Lindquist S 2002 Hsp90 as a capacitor of phenotypic variation; Nature (London) 417 618–624CrossRefGoogle Scholar
  15. Rutherford S L and Lindquist S 1998 Hsp90 as a capacitor for morphological evolution; Nature (London) 396 336–342CrossRefGoogle Scholar
  16. Sachs J and Malaney P 2002 The economic and social burden of malaria; Nature (London) 415 680–685CrossRefGoogle Scholar
  17. Sali A and Blundell T L 1993 Comparative protein modelling by satisfaction of spatial restraints; J. Mol. Biol. 234 779–815PubMedCrossRefGoogle Scholar

Copyright information

© Indian Academy of Sciences 2007

Authors and Affiliations

  • Ranjit Kumar
    • 1
  • Soundara Raghavan Pavithra
    • 1
  • Utpal Tatu
    • 1
  1. 1.Department of BiochemistryIndian Institute of ScienceBangaloreIndia

Personalised recommendations